Dendritic cells as adjuvants for immune-mediated resistance to tumors - PubMed (original) (raw)

Review

Dendritic cells as adjuvants for immune-mediated resistance to tumors

G Schuler et al. J Exp Med. 1997.

No abstract available

PubMed Disclaimer

Similar articles

• Why are dendritic cells central to cancer immunotherapy?
  Colaco CA. Colaco CA. Mol Med Today. 1999 Jan;5(1):14-7. doi: 10.1016/s1357-4310(98)01407-5. Mol Med Today. 1999. PMID: 10088127 Review.
• Novel perspectives on dendritic cell-based immunotherapy of cancer.
  Bonaccorsi I, Pezzino G, Morandi B, Ferlazzo G. Bonaccorsi I, et al. Immunol Lett. 2013 Sep-Oct;155(1-2):6-10. doi: 10.1016/j.imlet.2013.09.021. Epub 2013 Sep 26. Immunol Lett. 2013. PMID: 24076312 Review.
• Dendritic cell activation kinetics and cancer immunotherapy.
  Bellone M, Camporeale A, Boni A. Bellone M, et al. J Immunol. 2004 Mar 1;172(5):2727-8. doi: 10.4049/jimmunol.172.5.2727-a. J Immunol. 2004. PMID: 14978067 No abstract available.
• Dendritic cells and immunotherapy for malignant disease.
  Reid DC. Reid DC. Br J Haematol. 2001 Mar;112(4):874-87. doi: 10.1046/j.1365-2141.2001.02626.x. Br J Haematol. 2001. PMID: 11298582 Review. No abstract available.
• Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.
  Saxena M, Bhardwaj N. Saxena M, et al. Curr Opin Immunol. 2017 Aug;47:35-43. doi: 10.1016/j.coi.2017.06.003. Epub 2017 Jul 18. Curr Opin Immunol. 2017. PMID: 28732279 Free PMC article. Review.

Cited by

• Morphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients.
  Lee DH. Lee DH. Korean J Physiol Pharmacol. 2012 Aug;16(4):243-7. doi: 10.4196/kjpp.2012.16.4.243. Epub 2012 Aug 10. Korean J Physiol Pharmacol. 2012. PMID: 22915989 Free PMC article.
• Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA.
  Barrou B, Benoît G, Ouldkaci M, Cussenot O, Salcedo M, Agrawal S, Massicard S, Bercovici N, Ericson ML, Thiounn N. Barrou B, et al. Cancer Immunol Immunother. 2004 May;53(5):453-60. doi: 10.1007/s00262-003-0451-2. Epub 2004 Feb 4. Cancer Immunol Immunother. 2004. PMID: 14760510 Free PMC article. Clinical Trial.
• Efficient gene transduction by RGD-fiber modified recombinant adenovirus into dendritic cells.
  Asada-Mikami R, Heike Y, Kanai S, Azuma M, Shirakawa K, Takaue Y, Krasnykh V, Curiel DT, Terada M, Abe T, Wakasugi H. Asada-Mikami R, et al. Jpn J Cancer Res. 2001 Mar;92(3):321-7. doi: 10.1111/j.1349-7006.2001.tb01098.x. Jpn J Cancer Res. 2001. PMID: 11267943 Free PMC article.
• Tumor cells prevent mouse dendritic cell maturation induced by TLR ligands.
  Idoyaga J, Moreno J, Bonifaz L. Idoyaga J, et al. Cancer Immunol Immunother. 2007 Aug;56(8):1237-50. doi: 10.1007/s00262-006-0275-y. Epub 2007 Jan 20. Cancer Immunol Immunother. 2007. PMID: 17237931 Free PMC article.
• Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.
  Kalinski P, Urban J, Narang R, Berk E, Wieckowski E, Muthuswamy R. Kalinski P, et al. Future Oncol. 2009 Apr;5(3):379-90. doi: 10.2217/fon.09.6. Future Oncol. 2009. PMID: 19374544 Free PMC article. Review.

References

1. 1. Van Der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van Den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash DC) 1991;254:1643–1647. - PubMed
2. 1. Boon T, Cerottini J-C, Van Der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol. 1994;12:337–365. - PubMed
3. 1. Rosenberg SA, Kawakami Y, Robbins PF, Wang RF. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy. Adv Cancer Res. 1996;70:145–177. - PubMed
4. 1. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 1997;9:10–16. - PubMed
5. 1. Schuler G, Thurner B, Romani N. Dendritic cells: from ignored cells to major players in T-cell–mediated immunity. Int Arch Allergy Immunol. 1997;112:317–333. - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database